Professor Hugh Willison

  • Professor of Neurology (Immunology)
  • Professor of Neurology (School of Medicine)

telephone: 01413308384
email: Hugh.Willison@glasgow.ac.uk

Research interests

Professor Hugh Willison leads the Neuroimmunology Research Group within the Glasgow Biomedical Research Centre. The Neuroimmunology Group is concerned with dissecting out the pathogenesis of autoimmune neuropathies, using a wide variety of approaches, techniques and collaborations. Work in the lab in principally funded by The Wellcome Trust. The particular emphasis is on the role of anti-ganglioside antibodies in the post-infectious paralytic neuropathy termed Guillain Barré syndrome (GBS) and the GBS variant termed Miller Fisher syndrome (MFS). GBS has an incidence of 1-2:100,000 (500-1000 UK cases per year), very high health care costs, substantial morbidity, and a mortality of 5-10%. The overall aim of the Neuroimmunology Group is to solve the pathogenic cycle from origin to effects of anti-ganglioside antibodies and then design novel therapies and biomarkers. The projects running in the lab at present are as follows:

    • Identifying and characterising carbohydrate autoantigens using combinatorial glycoarrays
    • Understanding Campylobacter jejuni LPS structure and immunogenicity
    • Cloning & characterising anti-ganglioside autoantibodies
    • Modelling disease in a wide range of genetically modified mice
    • Developing therapeutic strategies from animal models
    • Clinical research on serotype/phenotype associations
    • Participation in clinical trials of neuropathy patients
    • Coordinating the UK arm of IGOS: International GBS Outcome Study, that aims to recruit and phenotype 1000 GBS cases worldwide over the next 3 years

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Clinical and biological determinants of disease course in Guillain-Barre syndrome: a prospective UK-wide clinical initiative.
    Guillain-Barre Support Group of the United Kingdom
    2013 - 2014
     
  • Defining the clinical relevance of demyelinating and axopathic autoantibodies in multiple sclerosis.
    Action Medical Research
    2013 - 2014
     
  • Development of a high throughput combinatorial microarray platform for identifying novel glycolipid targets in inflammatory neuropahties
    The Peripheral Nerve Society
    2013 - 2014
     
  • Monitoring distal nerve degeneration and regeneration in an active immunization mouse model of Guillain-Barre syndrome
    The Peripheral Nerve Society
    2011 - 2012
     
  • The structural and functional diversity of anti-glycolipid antibody repertoires and their nerve binding domains in human autoimmune neuropathy
    Wellcome Trust
    2011 - 2016
     
  • Neurofascin specific autoantibodies and the pathogenesis of MS
    Multiple Sclerosis Society
    2010 - 2013
     
  • Glycan Complexes as Novel Antigenic Targets in the Nervous System
    Wellcome Trust
    2008 - 2010
     
  • Glycosphingolipid antigen depletion as a novel strategy for treating autoimmune peripheral nerve diseases
    MRC
    2008 - 2011
     
  • Imaging brain metabolism in acute stroke patients
    Patrick Berthould Charitable Trust
    2007 - 2010
     
  • Capacity Building Award in Integrative Mammalian Biology
    BBSRC
    2007 - 2012
     
  • An analysis of gangliocide specific B cells in autoimmune disease
    Pathological Society of Great Britain and Ireland
    2007 - 2010
     
  • Anti-Sulphatide Antibodies in Multiple Sclerosis
    NHS Greater Glasgow and Clyde
    2006 - 2011
     
  • An integrated approach to novel mechanisms and therapeutic strategies in murine models of human autoimmune neuropathy
    Wellcome Trust
    2006 - 2011
     
  • Phenotypic analysis and therapeutic modulation of murine autoimmune neuropathy
    Patrick Berthould Charitable Trust
    2004 - 2007
     
  • Synthetic disialygalactose immunoadsorbents deplete anti-GQlb antibodies from autoimmune neuropathy sera
    The Guillain-Barre Syndrome Foundation International
    2004 - 2006
     
  • Glasgow Biomedical Research Centre
    Wellcome Trust
    2003 - 2006
     
  • The Pathogenesis of Autoimmune Neuropathy Associated with Anti-ganglioside Antibodies
    Wellcome Trust
    2000 - 2006
     

Publications

List by: Type | Date

Jump to: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1991 | 1990 | 1988 | 1987 | 1986 | 1985 | 1982
Number of items: 166.

2015

Delmont, E., Halstead, S., Galban-Horcajo, F., Yao, D., Desnuelle, C., and Willison, H. (2015) Improving the detection of IgM antibodies against glycolipids complexes of GM1 and galactocerebroside in multifocal motor neuropathy using glycoarray and ELISA assays. Journal of Neuroimmunology, 278, pp. 159-161. (doi:10.1016/j.jneuroim.2014.11.001) (PMID:25468269)

2014

Galban-Horcajo, F., Halstead, S. K., McGonigal, R., and Willison, H. J. (2014) The application of glycosphingolipid arrays to autoantibody detection in neuroimmunological disorders. Current Opinion in Chemical Biology, 18, pp. 78-86. (doi:10.1016/j.cbpa.2014.01.008)

Fewou, S.N., Plomp, J.J., and Willison, H.J. (2014) The pre-synaptic motor nerve terminal as a site for antibody-mediated neurotoxicity in autoimmune neuropathies and synaptopathies. Journal of Anatomy, 224(1), pp. 36-44. (doi:10.1111/joa.12088)

Willison, H. J., Galban-Horcajo, F., and Halstead, S. K. (2014) Antibodies to GM1: galactocerebroside complexes in multifocal motor neuropathy: it takes two to tango. Journal of Neurology, Neurosurgery and Psychiatry, 85(7), p. 715. (doi:10.1136/jnnp-2013-306050)

Yao, D. et al. (2014) Neuronal expression of galnac transferase is sufficient to prevent the age-related neurodegenerative phenotype of complex ganglioside-deficient mice. Journal of Neuroscience, 34(3), pp. 880-891. (doi:10.1523/JNEUROSCI.3996-13.2014)

2013

Reindl, M. et al. (2013) Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome. PLoS ONE, 8(12), e82337. (doi:10.1371/journal.pone.0082337)

Willison, H.J., and Goodyear, C.S. (2013) Glycolipid antigens and autoantibodies in autoimmune neuropathies. Trends in Immunology, 34(9), pp. 453-459. (doi:10.1016/j.it.2013.05.001)

Rupp, A., Cunningham, M.E., Yao, D., Furukawa, K., and Willison, H.J. (2013) The effects of age and ganglioside composition on the rate of motor nerve terminal regeneration following antibody-mediated injury in mice. Synapse, 67(7), pp. 382-389. (doi:10.1002/syn.21648)

Rupp, A.F., Galban-Horcajo, F., Bianchi, E., Dondi, M., Penderis, J., Cappell, J., Burgess, K., Matiasek, K., McGonigal, R., and Willison, H.J. (2013) Anti-GM2 ganglioside antibodies are a biomarker for acute canine polyradiculoneuritis. Journal of the Peripheral Nervous System, 18(1), pp. 75-88. (doi:10.1111/jns5.12011)

Galban-Horcajo, F., Fitzpatrick, A.M., Hutton, A.J., Dunn, S.M., Kalna, G., Brennan, K.M., Rinaldi, S., Yu, R.K., Goodyear, C.S., and Willison, H.J. (2013) Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy. European Journal of Neurology, 20(1), pp. 62-70. (doi:10.1111/j.1468-1331.2012.03767.x)

2012

Chavada, G., and Willison, H.J. (2012) Autoantibodies in immune-mediated neuropathies. Current Opinion in Neurology, 25(5), pp. 550-555. (doi:10.1097/WCO.0b013e328357a77f)

Willison, H.J., and Linington, C. (2012) Antibodies to MOG in NMO: a seasoned veteran finds a new role. Neurology, 79(12), pp. 1198-1199. (doi:10.1212/WNL.0b013e31826aadaf)

Elliott, C. et al. (2012) Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis. Brain, 135(6), pp. 1819-1833. (doi:10.1093/brain/aws105)

Fewou, S.N., Rupp, A., Nickolay, L.E., Carrick, K., Greenshields, K.N., Pediani, J., Plomp, J.J., and Willison, H.J. (2012) Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy. Journal of Clinical Investigation, 122(3), pp. 1037-1051. (doi:10.1172/JCI59110)

Huizinga, R. et al. (2012) Sialylation of campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice. PLoS ONE, 7(3), e34416. (doi:10.1371/journal.pone.0034416) (PMID:22470569) (PMCID:PMC3314637)

Islam, Z. et al. (2012) Guillain-Barré Syndrome-related campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies. PLoS ONE, 7(8), e43976. (doi:10.1371/journal.pone.0043976)

Rinaldi, S., Brennan, K.M., and Willison, H.J. (2012) Combinatorial glycoarray. Methods in Molecular Biology, 808, pp. 413-423. (doi:10.1007/978-1-61779-373-8_28)

Rupp, A., Morrison, I., Barrie, J.A., Halstead, S.K., Townson, K.H., Greenshields, K.N., and Willison, H.J. (2012) Motor nerve terminal destruction and regeneration following anti-ganglioside antibody and complement-mediated injury: An in and ex vivo imaging study in the mouse. Experimental Neurology, 233(2), pp. 836-848. (doi:10.1016/j.expneurol.2011.12.010)

2011

Höke, A., and Willison, H.J. (2011) In memoriam: remembering John W. 'Jack' Griffin M.D. Nature Reviews Neurology, 7, pp. 361-362. (doi:10.1038/nrneurol.2011.94)

Barnett, M. H., Barnett, Y., Burke, D., and Willison, H. (2011) Spinal nerve root hypertrophy in chronic ataxic neuropathy with antiglycolipid IgM antibodies. Journal of Neurology, Neurosurgery and Psychiatry, 82(1), p. 97. (doi:10.1136/jnnp.2010.205096)

Brennan, K.M. et al. (2011) Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis. Journal of Neuroimmunology, 238(1-2), pp. 87-95. (doi:10.1016/j.jneuroim.2011.08.002)

Fitzpatrick, A.M., Mann, C.A., Barry, S., Brennan, K., Overell, J.R., and Willison, H.J. (2011) An open label clinical trial of complement inhibition in multifocal motor neuropathy. Journal of the Peripheral Nervous System, 16(2), pp. 84-91. (doi:10.1111/j.1529-8027.2011.00328.x)

Hartung, H.-P., Lehmann, H.C., and Willison, H.J. (2011) Peripheral neuropathies: Establishing common clinical research standards for CIDP. Nature Reviews Neurology, 7(5), pp. 250-251. (doi:10.1038/nrneurol.2011.46)

Nilsson, E.C. et al. (2011) The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis. Nature Medicine, 17(1), pp. 105-109. (doi:10.1038/nm.2267)

Willison, H. (2011) Reply: Neurofascin as target of autoantibodies in Guillain-Barre syndrome. Brain, 134(5), e174-e174. (doi:10.1093/brain/awq375)

Willison, H.J. (2011) Biomarkers in experimental models of antibody-mediated neuropathies. Journal of the Peripheral Nervous System, 16, pp. 60-62. (doi:10.1111/j.1529-8027.2011.00310.x)

Zitman, F.M.P. et al. (2011) Neuropathophysiological potential of Guillain-Barré syndrome anti-ganglioside-complex antibodies at mouse motor nerve terminals. Clinical and Experimental Neuroimmunology, 2(3), pp. 59-67. (doi:10.1111/j.1759-1961.2011.00022.x)

Zitman, F.M.P., Todorov, B., Verschuuren, J.J., Jacobs, B.C., Furukawa, K., Furukawa, K., Willison, H.J., and Plomp, J.J. (2011) Neuromuscular synaptic transmission in aged ganglioside-deficient mice. Neurobiology of Aging, 32(1), pp. 157-167. (doi:10.1016/j.neurobiolaging.2009.01.007)

2010

McGonigal, R., Rowan, E.G., Greenshields, K.N., Halstead, S.K., Humphreys, P.D., Rother, R.P., Furukawa, K., and Willison, H.J. (2010) Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice. Brain, 133(7), pp. 1944-1960. (doi:10.1093/brain/awq119)

Willison, H.J. (2010) Sugar refining reveals a further specificity for autoantibodies in multifocal motor neuropathy. Journal of Neurology, Neurosurgery and Psychiatry, 81(7), pp. 707-708. (doi:10.1136/jnnp.2010.205310)

Zitman, F.M.P., Todorov, B., Furukawa, K., Furukawa, K., Willison, H.J., and Plomp, J.J. (2010) Total ganglioside ablation at mouse motor nerve terminals alters neurotransmitter release level. Synapse, 64(4), pp. 335-338. (doi:10.1002/syn.20747)

Willison, H.J., and Wraith, D.C. (2010) A hazardous vapour trail from abattoir to neuropathy clinic. Lancet Neurology, 9(1), pp. 22-24. (doi:10.1016/S1474-4422(09)70323-0)

Lockington, D., Imrie, F., Gillen, J., Fitzpatrick, A., and Willison, H. (2010) Visual improvement in established central retinal vein occlusion with long standing macular edema following systemic eculizumab treatment. Canadian Journal of Ophthalmology = Journal canadien d'ophtalmologie, 45(6), p. 649. (doi:10.3129/i10-060)

Rinaldi, S., Brennan, K.M., and Willison, H.J. (2010) Heteromeric glycolipid complexes as modulators of autoantibody and lectin binding. Progress in Lipid Research, 49(1), pp. 87-95. (doi:10.1016/j.plipres.2009.09.001)

2009

Jacobs, B.C., and Willison, H.J. (2009) Peripheral neuropathies: biomarkers for axonal damage in immune-mediated neuropathy. Nature Reviews Neurology, 5(11), pp. 584-585. (doi:10.1038/nrneurol.2009.161)

Reid, J.M., Foley, P., and Willison, H.J. (2009) Voltage-gated potassium channel-associated limbic encephalitis in the west of Scotland: case reports and literature review. Scottish Medical Journal, 54(4), pp. 27-31. (doi:10.1258/rsmsmj.54.4.27)

Plomp, J.J., and Willison, H.J. (2009) Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction. Journal of Physiology, 587(16), pp. 3979-3999. (doi:10.1113/jphysiol.2009.171702)

Iorio, R., Capone, F., Iannaccone, E., Willison, H.J., Modoni, A., Tonali, P.A., and Silvestri, G. (2009) SIADH in a patient with sensory ataxic neuropathy with anti-disialosyl antibodies (CANOMAD). Journal of Neurology, 256(7), pp. 1177-1179. (doi:10.1007/s00415-009-5071-0)

Greenshields, K.N. et al. (2009) The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice. Journal of Clinical Investigation, 119(3), pp. 595-610. (doi:10.1172/JCI37338)

Liu, J., Willison, H., and Pedrosa-Domellof, F. (2009) Immunolocalization of GQ1b and Related Gangliosides in Human Extraocular Neuromuscular Junctions and Muscle Spindles. Investigative Ophthalmology and Visual Science, 50(7), pp. 3226-3232.

Lunn, M.P.T., and Willison, H.J. (2009) Diagnosis and treatment in inflammatory neuropathies. Journal of Neurology, Neurosurgery and Psychiatry, 80(3), pp. 249-258.

Lunn, M., and Willison, H. (2009) Diagnosis and treatment in inflammatory neuropathies (Reprinted from Journal of Neurology, Neurosurgery, and Psychiatry, vol 80, pg 249-58, 2009). Postgraduate Medical Journal, 85(1006), pp. 437-446.

Marioni, R. et al. (2009) Peripheral Levels of Fibrinogen, C-Reactive Protein, and Plasma Viscosity Predict Future Cognitive Decline in Individuals Without DementiaPeripheral Neuropathies Biomarkers for Axonal Damage in Immune-Mediated Neuropathy. Psychosomatic Medicine, 71(8), pp. 901-906.

Rinaldi, S., Brennan, K., Goodyear, C., O'Leary, C., Schiavo, G., Crocker, P., and Willison, H. (2009) Analysis of lectin binding to glycolipid complexes using combinatorial glycoarrays. Glycobiology, 19(7), pp. 789-796. (doi:10.1093/glycob/cwp049)

Silajdzic, E., Willison, H., Furukawa, K., and Barnett, S. (2009) In Vitro Analysis of Glial Cell Function in Ganglioside-deficient Mice. Journal of Neuroscience Research, 87(11), pp. 2467-2483. (doi:10.1002/jnr.22085 )

2008

Halstead, S., Zitman, F., Humphreys, P., Greenshields, K., Verschuuren, J., Jacobs, B., Rother, R., Plomp, J., and Willison, H. (2008) Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain, 131(5), pp. 1197-1208. (doi:10.1093/brain/awm316 )

Court, F., Gillingwater, T., Melrose, S., Sherman, D., Greenshields, K., Morton, A., Harris, J., Willison, H., and Ribchester, R. (2008) Identity, developmental restriction and reactivity of extralaminar cells capping mammalian neuromuscular junctions. Journal of Cell Science, 121(23), pp. 3901-3911.

Halstead, S., Humphreys, P., Zitman, F., Hamer, J., Plomp, J., and Willison, H. (2008) C5 inhibitor rEV576 protects against neural injury in an in vitro mouse model of Miller Fisher syndrome. Journal of the Peripheral Nervous System, 13(3), pp. 228-235.

Jacobs, B., Koga, M., van Rijs, W., Geleijns, K., van Doom, P., Willison, H., and Yuki, N. (2008) Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barre syndrome. Journal of Neuroimmunology, 194(1-2), pp. 181-190.

Rinaldi, S., and Willison, H. (2008) Ganglioside antibodies and neuropathies. Current Opinion in Neurology, 21(5), pp. 540-546.

Townson, K., Speak, A., Greenshields, K., Goodyear, C., Willison, H., and Platt, F. (2008) Glycosphingolipid depletion in PC12 cells using iminosugars protects neuronal membranes from anti-ganglioside antibody mediated injury. Journal of Neuroimmunology, 203(1), pp. 33-38. (doi:10.1016/j.jneuroim.2008.06.033)

Willison, H., Halstead, S., Bevenidge, E., Zitman, F., Greenshields, K., Morgan, B., and Plomp, J. (2008) The role of complement and complement regulators in mediating motor nerve terminal injury in murine models of Guillain-Barre syndrome. Journal of Neuroimmunology, 201, pp. 172-182.

Willison, H., and Plomp, J. (2008) Anti-ganglioside antibodies and the presynaptic motor nerve terminal. Myasthenia Gravis and Related Disorders, 1132, pp. 114-123.

Zitman, F.M.P., Todorov, B., Jacobs, B.C., Verschuuren, J.J., Furukawa, K., Willison, H.J., and Plomp, J.J. (2008) Neuromuscular synaptic function in mice lacking major subsets of gangliosides. Neuroscience, 156(4), pp. 885-897. (doi:10.1016/j.neuroscience.2008.08.034)

2007

Willison, H.J. (2007) Gangliosides as targets for autoimmune injury to the nervous system. Journal of Neurochemistry, 103(s1), pp. 143-149. (doi:10.1111/j.1471-4159.2007.04718.x)

Nachamkin, I. et al. (2007) Patterns of Guillain-Barre syndrome in children - Results from a Mexican population. Neurology, 69, pp. 1665-1671.

Overell, J.R., Hsieh, S.-T., Odaka, M., Yuki, N., and Willison, H.J. (2007) Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders. Cochrane Database of Systematic Reviews(1), CD004761. (doi:10.1002/14651858.CD004761.pub2)

Townson, K. et al. (2007) Solid phase immunoadsorption for therapeutic and analytical studies on neuropathy-associated anti-GM1 antibodies. Glycobiology, 17, pp. 294-303. (doi:10.1093/glycob/cwl074)

Townson, K. et al. (2007) Sulfatide binding properties of murine and human antiganglioside antibodies. Glycobiology, 17, pp. 1156-1166. (doi:10.1093/glycob/cwm095)

2006

Willison, H.J. (2006) Ganglioside complexes as targets for antibodies in Miller Fisher syndrome. Journal of Neurology, Neurosurgery and Psychiatry, 77(9), pp. 1002-1003. (doi:10.1136/jnnp.2006.094441)

Deinhardt, K., Berninghausen, O., Willison, H.J., Hopkins, C.R., and Schiavo, G. (2006) Tetanus toxin is internalized by a sequential clathrin-dependent mechanism initiated within lipid microdomains and independent of epsin1. Journal of Cell Biology, 174(3), pp. 459-71. (doi:10.1083/jcb.200508170)

Avril, T., North, S., Haslam, S., Willison, H., and Crocker, P. (2006) Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha 2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha 2,8-sialyltransferase gene expression. Journal of Leukocyte Biology, 80, pp. 787-796. (doi:10.1189/jlb.1005559)

Avril, T., Wagner, E., Willison, H., and Crocker, P. (2006) Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides. Infection and Immunity, 74, pp. 4133-4141. (doi:10.1128/IAI.02094-05)

Willison, H.J. (2006) Basic and clinical aspects of autoimmune disorders in peripheral nerves. Acta Neurologica Scandinavica, 113(s183), pp. 14-18. (doi:10.1111/j.1600-0404.2006.00607.x)

2005

Halstead, S.K., Morrison, I., O'Hanlon, G.M., Humphreys, P.D., Goodfellow, J.A., Plomp, J.J., and Willison, H.J. (2005) Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions. Glia, 52(3), pp. 177-189. (doi:10.1002/glia.20228)

Willison, H.J. (2005) Ganglioside complexes: new autoantibody targets in Guillain-Barré syndromes. Nature Clinical Practice Neurology, 1(1), pp. 2-3. (doi:10.1038/ncpneuro0001)

Boffey, J., Odaka, M., Nicoll, D., Wagner, E.R., Townson, K., Bowes, T., Conner, J., Furukawa, K., and Willison, H.J. (2005) Characterisation of the immunoglobulin variable region gene usage encoding the murine anti-ganglioside antibody repertoire. Journal of Neuroimmunology, 165(1-2), pp. 92-103. (doi:10.1016/j.jneuroim.2005.04.011)

Willison, H.J. (2005) The immunobiology of Guillain-Barré syndromes. Journal of the Peripheral Nervous System, 10(2), pp. 94-112. (doi:10.1111/j.1085-9489.2005.0010202.x)

Bullens, R., Halstead, S., OHanlon, G., Veitch, J., Molenaar, P., Willison, H., and Plomp, J. (2005) Concanavalin A inhibits pathophysiological effects of anti-ganglioside GQ1b antibodies at the mouse neuromuscular synapse. Muscle and Nerve, 31, pp. 751-760. (doi:10.1002/mus.20327)

Goodfellow, J. et al. (2005) Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy. Journal of Neuroscience, 25, pp. 1620-1628. (doi:10.1523/JNEUROSCI.4279-04.2005)

Halstead, S., Humphreys, P., Goodfellow, J., Wagner, E., Smith, R., and Willison, H. (2005) Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome. Annals of Neurology, 58, pp. 203-210. (doi:10.1002/ana.20546)

Overell, J., and Willison, H. (2005) Recent developments in Miller Fisher syndrome and related disorders. Current Opinion in Neurology, 18, pp. 562-566.

2004

Lee, G., Jeong, Y., Wirguin, I., Hays, A.P., Willison, H.J., and Latov, N. (2004) Induction of human IgM and IgG anti-GM1 antibodies in transgenic mice in response to lipopolysaccharides from Campylobacter jejuni. Journal of Neuroimmunology, 146(1-2), pp. 63-75. (doi:10.1016/j.jneuroim.2003.10.045)

Andersen, S., Ling, C., Zhang, P., Townson, K., Willison, H., and Bundle, D. (2004) Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barre syndrome. Organic and Biomolecular Chemistry, 2, pp. 1199-1212. (doi:10.1039/b400029c)

Boffey, J., Nicholl, D., Wagner, E., Townson, K., Goodyear, C., Furukawa, K., Conner, J., and Willison, H. (2004) Innate murine B cells produce anti-disialosyl antibodies reactive with Campylobacter jejuni LPS and gangliosides that are polyreactive and encoded by a restricted set of unmutated V genes. Journal of Neuroimmunology, 152, pp. 98-111. (doi:10.1016/j.jneuroim.2004.04.002)

Halstead, S., OHanlon, G., Humphreys, P., Morrison, D., Morgan, B., Todd, A., Plomp, J., and Willison, H. (2004) Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain, 127, pp. 2109-2123. (doi:10.1093/brain/awh231)

Kieseier, B.C., Kiefer, R., Gold, R., Hemmer, B., Willison, H.J., and Hartung, H.P. (2004) Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle and Nerve, 30, pp. 131-156. (doi:10.1002/mus.20076)

Willison, H., Townson, K., Veitch, J., Boffey, J., Isaacs, N., Andersen, S., Zhang, P., Ling, C., and Bundle, D. (2004) Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune nueropathy sera. Brain, 127, pp. 680-691. (doi:10.1093/brain/awh083)

2003

O'Hanlon, G.M., Hirst, T.R., and Willison, H.J. (2003) Ganglioside GM1 binding toxins and human neuropathy-associated IgM antibodies differentially promote neuritogenesis in a PC12 assay. Neuroscience Research, 47(4), pp. 383-390. (doi:10.1016/S0168-0102(03)00239-6)

Jacobs, B.C., O'Hanlon, G.M., Bullens, R.W.M., Veitch, J., Plomp, J.J., and Willison, H.J. (2003) Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding. Brain, 126(10), pp. 2220-2234. (doi:10.1093/brain/awg235)

Bullens, R.W.M., O'Hanlon, G.M., Wagner, E., Molenaar, P.C., Furukawa, K., Furukawa, K., Plomp, J.J., and Willison, H.J. (2003) Roles of complex gangliosides at the neuromuscular junction. Annals of the New York Academy of Sciences, 998(1), pp. 401-403. (doi:10.1196/annals.1254.051)

Willison, H.J., and Winer, J.B. (2003) Clinical evaluation and investigation of neuropathy. Journal of Neurology, Neurosurgery and Psychiatry, 74(s2), ii3-ii8. (doi:10.1136/jnnp.74.suppl_2.ii3)

McCrone, P. et al. (2003) Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. European Journal of Neurology, 10, pp. 687-694.

OHanlon, G., Humphreys, P., Goldman, R., Halstead, S., Bullens, R., Plomp, J., Ushkaryov, Y., and Willison, H. (2003) Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury. Brain, 126, pp. 2497-2509. (doi:10.1093/brain/awg254)

Ooi, M.H. et al. (2003) Adenovirus type 21-associated acute flaccid paralysis during an outbreak of hand-foot-and-mouth disease in Sarawak, Malaysia. Clinical Infectious Diseases, 36(5), pp. 550-559. (doi:10.1086/367648)

Pritchard, J., Gray, I., Idrissova, Z., Lecky, B., Sutton, I., Swan, A., Willison, H., Winer, J., and Hughes, R. (2003) A randomized controlled trial of recombinant interferon-beta 1a in Guillain-Barre syndrome. Neurology, 61, pp. 1282-1284.

Pritchard, J., Hughes, R.A.C., Rees, J.H., Willison, H.J., and Nicoll, J.A.R. (2003) Apolipoprotein E genotypes and clinical outcome in Guillain-Barre syndrome. Journal of Neurology, Neurosurgery and Psychiatry, 74, pp. 971-973.

Solomon, T., and Willison, H. (2003) Infectious causes of acute flaccid paralysis. Current Opinion in Infectious Diseases, 16, pp. 375-381. (doi:10.1097/01.qco.0000092807.64370.1e)

2002

Willison, H.J. (2002) Anti-glycolipid antibodies in the diagnosis of autoimmune neuropathies. Revue Neurologique, 158(123), pp. 16-20.

Willison, H.J., and Yuki, N. (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain, 125(12), pp. 2591-2625. (doi:10.1093/brain/awf272)

Hartung, H.-P., Willison, H.J., and Kieseier, B.C. (2002) Acute immunoinflammatory neuropathy: update on Guillain-Barré syndrome. Current Opinion in Neurology, 15(5), pp. 571-577.

Bowes, T., Wagner, E.R., Boffey, J., Nicholl, D., Cochrane, L., Benboubetra, M., Conner, J., Furukawa, K., Furukawa, K., and Willison, H.J. (2002) Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome. Infection and Immunity, 70(9), pp. 5008-5018. (doi:10.1128/IAI.70.9.5008-5018.2002)

Bullens, R.W.M., O'Hanlon, G.M., Wagner, E., Molenaar, P.C., Furukawa, K., Furukawa, K., Plomp, J.J., and Willison, H.J. (2002) Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function. Journal of Neuroscience, 22(16), pp. 6876-6884.

O'Hanlon, G.M., Bullens, R.W.M., Plomp, J.J., and Willison, H.J. (2002) Complex gangliosides as autoantibody targets at the neuromuscular junction in Miller Fisher syndrome: a current perspective. Neurochemical Research, 27(7-8), pp. 697-709. (doi:10.1023/A:1020284302718)

Jacobs, B.C., Bullens, R.W.M., O'Hanlon, G.M., Ang, C.W., Willison, H.J., and Plomp, J.J. (2002) Detection and prevalence of α-latrotoxin-like effects of serum from patients with Guillain-Barré syndrome. Muscle and Nerve, 25(4), pp. 549-558. (doi:10.1002/mus.10060)

Ang, C.W., Laman, J.D., Willison, H.J., Wagner, E.R., Endtz, H.P., De Klerk, M.A., Tio-Gillen, A.P., Van den Braak, N., Jacobs, B.C., and Van Doorn, P.A. (2002) Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. Infection and Immunity, 70(3), pp. 1202-1208. (doi:10.1128/IAI.70.3.1202-1208.2002)

Willison, H.J., Stoll, G., Toyka, K.V., Berger, T., and Hartung, H.-P. (2002) Autoimmunity and inflammation in the peripheral nervous system. Trends in Neurosciences, 25(3), pp. 127-129. (doi:10.1016/S0166-2236(00)02120-2)

Comi, G. et al. (2002) A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. Journal of Neurology, 249, pp. 1370-1377. (doi:10.1007/s00415-002-0808-z)

2001

Willison, H.J. (2001) Fine specificity of anti-GQ1b antibodies and clinical features. Journal of the Neurological Sciences, 185(1), pp. 1-2. (doi:10.1016/S0022-510X(01)00465-8)

Serrano-Munuera, C. et al. (2001) Antiganglioside antibodies in acute self-limiting ataxic neuropathy: incidence and significance. Journal of Neuroimmunology, 120(1-2), pp. 78-83. (doi:10.1016/S0165-5728(01)00428-3)

Hadden, R., Gregson, N., Gold, R., Willison, H., and Hughes, R. (2001) Guillain-Barre syndrome serum and anti-Campylobacter antibody do not exacerbate experimental autoimmune neuritis. Journal of Neuroimmunology, 119, pp. 306-316.

Hughes, R. et al. (2001) Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Annals of Neurology, 50, pp. 195-201.

O'Hanlon, G.M. et al. (2001) Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain, 124(5), pp. 893-906. (doi:10.1093/brain/124.5.893)

Willison, H. et al. (2001) The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain, 124, pp. 1968-1977.

2000

Willison, H.J., Ang, W., Gilhus, N.E., Graus, F., Liblau, R., Vedeler, C., and Vincent, A. (2000) EFNS task force report: a questionnaire-based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres. European Journal of Neurology, 7(6), pp. 625-628. (doi:10.1046/j.1468-1331.2000.00158.x)

O'Leary, C.P., and Willison, H.J. (2000) The role of antiglycolipid antibodies in peripheral neuropathies. Current Opinion in Neurology, 13(5), pp. 583-588.

Bensa, S., Hadden, R.D.M., Hahn, A., Hughes, R.A.C., and Willison, H.J. (2000) Randomized controlled trial of brain-derived neurotrophic factor in Guillain-Barré syndrome: a pilot study. European Journal of Neurology, 7(4), pp. 423-426. (doi:10.1046/j.1468-1331.2000.00096.x)

Bullens, R.W.M., O'Hanlon, G.M., Goodyear, C.S., Molenaar, P.C., Conner, J., Willison, H.J., and Plomp, J.J. (2000) Anti-GQ1b antibodies and evoked acetylcholine release at mouse motor endplates. Muscle and Nerve, 23(7), pp. 1035-1043. (doi:10.1002/1097-4598(200007)23:7<1035::AID-MUS5>3.0.CO;2-R)

Lough, J.C., Rafferty, D., McColl, J.H., Bell, F., and Willison, H.J. (2000) The application of control limits analysis to the myometric assessment of motor performance in neuropathy patients. European Journal of Neurology, 7(4), pp. 427-434. (doi:10.1046/j.1468-1331.2000.00095.x)

Ponsford, S., Willison, H.J., Veitch, J., Morris, R., and Thomas, P.K. (2000) Long-term clinical and neurophysiological follow-up of patients with peripheral, neuropathy associated with benign monoclonal gammopathy. Muscle and Nerve, 23(2), pp. 164-174. (doi:10.1002/(SICI)1097-4598(200002)23:2<164::AID-MUS4>3.0.CO;2-Y)

O'Hanlon, G.M., Veitch, J., Gallardo, E., Illa, I., Chancellor, A.M., and Willison, H.J. (2000) Peripheral neuropathy associated with anti-GM2 ganglioside antibodies: clinical and immunopathological studies. Autoimmunity, 32(2), pp. 133-144.

1999

Willison, H.J., and O'Hanlon, G.M. (1999) The immunopathogenesis of Miller Fisher syndrome. Journal of Neuroimmunology, 100(1-2), pp. 3-12. (doi:10.1016/S0165-5728(99)00213-1)

Goodyear, C.S., O'Hanlon, G.M., Plomp, J.J., Wagner, E.R., Cochrane, L., Bullens, R.W.M., Molenaar, P.C., Conner, J., and Willison, H.J. (1999) Monoclonal antibodies raised against Guillain-Barr. Journal of Clinical Investigation, 104(6), pp. 697-708. (doi:10.1172/JCI6837)

Prendergast, M.M., Willison, H.J., and Moran, A.P. (1999) Human monoclonal immunoglobulin M antibodies to ganglioside GM1 show diverse cross-reactivities with lipopolysaccharides of Campylobacter jejuni strains associated with Guillain-Barré syndrome. Infection and Immunity, 67(7), pp. 3698-3701.

Paparounas, K., O'Hanlon, G.M., O'Leary, C.P., Rowan, E.G., and Willison, H.J. (1999) Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro. Brain, 122(5), pp. 807-816. (doi:10.1093/brain/122.5.807)

Ballantyne, J.P. et al. (1999) Management of drug budgets: neurologists do not have confidence in Glasgow's method of managing drugs budget. British Medical Journal, 318(7187), p. 874. (doi:10.1136/bmj.318.7187.874)

Weiss, M.D., Dalakas, M.C., Lauter, C.J., Willison, H.J., and Quarles, R.H. (1999) Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinemia. Journal of Neuroimmunology, 95(1-2), pp. 174-184. (doi:10.1016/S0165-5728(98)00247-1)

Ho, T.W. et al. (1999) Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Annals of Neurology, 45(2), pp. 168-173. (doi:10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6)

Benatar, M., Willison, H.J., and Vincent, A. (1999) Immune-mediated peripheral neuropathies and voltage-gated sodiums channels. Muscle and Nerve, 22(1), pp. 108-110. (doi:10.1002/(SICI)1097-4598(199901)22:1<108::AID-MUS16>3.0.CO;2-I)

Willison, H.J., Veitch, J., Swan, A.V., Baumann, N., Comi, G., Gregson, N.A., Illa, I., Zielasek, J., and Hughes, R.A.C. (1999) Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies. European Journal of Neurology, 6(1), pp. 71-77. (doi:10.1046/j.1468-1331.1999.610071.x)

1998

Sheikh, K.A. et al. (1998) Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility. Neurology, 51(2), pp. 371-378.

O'Hanlon, G.M., Paterson, G.J., Veitch, J., Wilson, G., and Willison, H.J. (1998) Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies. Acta Neuropathologica, 95(6), pp. 605-616.

1997

Benatar, M.G., Willison, H.J., and Vincent, A. (1997) Lack of effect of Miller Fisher sera/plasmas on transmitter release from PC12 cells. Journal of Neuroimmunology, 80(1-2), pp. 1-5. (doi:10.1016/S0165-5728(97)00127-6)

Jacobs, B.C., O'Hanlon, G.M., Breedland, E.G., Veitch, J., van Doorn, P.A., and Willison, H.J. (1997) Human IgM paraproteins demonstrate shared reactivity between Campylobacter jejuni lipopolysaccharides and human peripheral nerve disialylated gangliosides. Journal of Neuroimmunology, 80(1-2), pp. 23-30. (doi:10.1016/S0165-5728(97)00130-6 )

Willison, H.J., O'Hanlon, G.M., Paterson, G., O'Leary, C.P., Veitch, J., Wilson, G., Roberts, M., Tang, T., and Vincent, A. (1997) Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome. Journal of Infectious Diseases, 176(s2), s144-s149. (doi:10.1086/513799)

O'Leary, C.P., and Willison, H.J. (1997) Autoimmune ataxic neuropathies (sensory ganglionopathies). Current Opinion in Neurology, 10(5), pp. 366-370.

O'Leary, C.P., Mann, A.C., Lough, J., and Willison, H.J. (1997) Muscle hypertrophy in multifocal motor neuropathy is associated with continuous motor unit activity. Muscle and Nerve, 20(4), pp. 479-485. (doi:10.1002/(SICI)1097-4598(199704)20:4<479::AID-MUS11>3.0.CO;2-U)

Ho, T.W. et al. (1997) Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology, 48(3), pp. 717-724.

1996

Willison, H.J., O'Hanlon, G.M., Paterson, G., Veitch, J., Wilson, G., Roberts, M., Tang, T., and Vincent, A. (1996) A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18. Journal of Clinical Investigation, 97(5), pp. 1155-1164.

O'Hanlon, G.M., Paterson, G.J., Wilson, G., Doyle, D., McHardie, P., and Willison, H.J. (1996) Anti-GM1 ganglioside antibodies cloned from autoimmune neuropathy patients show diverse binding patterns in the rodent nervous system. Journal of Neuropathology and Experimental Neurology , 55(2), pp. 184-195.

Jamieson, D.R., Teasdale, E., and Willison, H.J. (1996) False localising signs in the spinal cord. British Medical Journal, 312(7025), pp. 243-244.

Hartung, H.-P., Willison, H.J., Jung, S., Pette, M., Toyka, K.V., and Giegerich, G. (1996) Autoimmune responses in peripheral nerve. Springer Seminars in Immunopathology, 18(1), pp. 97-123. (doi:10.1007/BF00792612)

1995

O'Leary, C.P., and Willison, H.J. (1995) Immunological investigation. Current Opinion in Neurology, 8(5), pp. 349-353.

Paterson, G., Wilson, G., Kennedy, P.G., and Willison, H.J. (1995) Analysis of anti-GM1 ganglioside IgM antibodies cloned from motor neuropathy patients demonstrates diverse V region gene usage with extensive somatic mutation. Journal of Immunology, 155(6), pp. 3049-3059.

Roberts, M., Willison, H.J., Vincent, A., and Newsom-Davis, J. (1995) Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Annals of Neurology, 38(1), pp. 111-118. (doi:10.1002/ana.410380118)

Vincent, A., Roberts, M., Willison, H.J., Lang, B., and Newsom-Davis, J. (1995) Autoantibodies, neurotoxins and the nervous system. Journal of Physiology: Paris, 89(3), pp. 129-136. (doi:10.1016/0928-4257(96)80110-0)

1994

Willison, H.J., Almemar, A., Veitch, J., and Thrush, D. (1994) Acute ataxic neuropathy with cross-reactive antibodies to GD1b and GD3 gangliosides. Neurology, 44(12), pp. 2395-2397.

Willison, H.J. (1994) Antiglycolipid antibodies in peripheral neuropathy: fact or fiction? Journal of Neurology, Neurosurgery and Psychiatry, 57(11), pp. 1303-1307. (doi:10.1136/jnnp.57.11.1303)

Willison, H.J., Chancellor, A.M., Veitch, J., Kennedy, P.G., and Warlow, C.P. (1994) Immunoglobulin G subclasses are normal in motor neuron disease. Journal of the Neurological Sciences, 124(1), pp. 115-116. (doi:10.1016/0022-510X(94)90021-3)

Vincent, A., Barrett-Jolley, R., Shillito, P., Hart, I., Beeson, D., MacLennan, C., Nicolle, M., Lang, B., Roberts, M., and Willison, H.J. (1994) Involvement of cation channels in autoimmune disease. Biochemical Society Transactions, 22(2), pp. 488-491.

Thomas, P.K., and Willison, H.J. (1994) Paraproteinaemic neuropathy. Baillière's Clinical Neurology, 3(1), pp. 129-147.

Willison, H.J., Paterson, G., Kennedy, P.G., and Veitch, J. (1994) Cloning of human anti-GM1 antibodies from motor neuropathy patients. Annals of Neurology, 35(4), pp. 471-478. (doi:10.1002/ana.410350416)

Willison, H.J., and Veitch, J. (1994) Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. Journal of Neuroimmunology, 50(2), pp. 159-165. (doi:10.1016/0165-5728(94)90042-6)

Roberts, M., Vincent, A., Newsom-Davis, J., and Willison, H.J. (1994) Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet, 343(8895), pp. 454-5. (doi:10.1016/S0140-6736(94)92694-8)

de Silva, R.N., Willison, H.J., Doyle, D., Weir, A.I., Hadley, D.M., and Thomas, A.M. (1994) Nerve root hypertrophy in chronic inflammatory demyelinating polyneuropathy. Muscle and Nerve, 17(2), pp. 168-170. (doi:10.1002/mus.880170206)

Herron, B., Willison, H.J., Veitch, J., Roelcke, D., Illis, L.S., and Boulton, F.E. (1994) Monoclonal IgM cold agglutinins with anti-Pr1d specificity in a patient with peripheral neuropathy. Vox Sanguinis, 67(1), pp. 58-63. (doi:10.1111/j.1423-0410.1994.tb05039.x)

1993

Willison, H.J., Paterson, G., Veitch, J., Inglis, G., and Barnett, S.C. (1993) Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins. Journal of Neurology, Neurosurgery and Psychiatry, 56(11), pp. 1178-1183. (doi:10.1136/jnnp.56.11.1178)

Willison, H.J., and Kennedy, P.G. (1993) Gangliosides and bacterial toxins in Guillain-Barré syndrome. Journal of Neuroimmunology, 46(1-2), pp. 105-12. (doi:10.1016/0165-5728(93)90239-U)

Willison, H.J., and Kennedy, P.G. (1993) The fine specificity of anti-GM1 antibodies. Quarterly Journal of Medicine, 86(3), pp. 216-217.

Willison, H. J., Veitch, J., Paterson, G., and Kennedy, P. G. E. (1993) Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. Journal of Neurology, Neurosurgery and Psychiatry, 56(2), pp. 204-206. (doi:10.1136/jnnp.56.2.204)

Willison, H.J., Chancellor, A.M., Paterson, G., Veitch, J., Singh, S., Whitelaw, J., Kennedy, P.G., and Warlow, C.P. (1993) Antiglycolipid antibodies, immunoglobulins and paraproteins in motor neuron disease: a population based case-control study. Journal of the Neurological Sciences, 114(2), pp. 209-215. (doi:10.1016/0022-510X(93)90300-N)

1991

Gregson, N.A., Jones, D., Thomas, P.K., and Willison, H.J. (1991) Acute motor neuropathy with antibodies to GM1 ganglioside. Journal of Neurology, 238(8), pp. 447-451.

Willison, H.J., Gale, A.N., and McLaughlin, J.E. (1991) Creutzfeldt-Jacob disease following cadaveric dura mater graft. Journal of Neurology, Neurosurgery and Psychiatry, 54(10), p. 940.

1990

Willison, H.J., Kendall, B.E., Trend, P., Thomas, P.K., Symon, L., and Thrush, D. (1990) Spinal arteriovenous malformation unmasked during intravenous urography. Journal of Neurology, Neurosurgery and Psychiatry, 53(2), pp. 175-176.

Quarles, R.H., Ilyas, A.A., and Willison, H.J. (1990) Antibodies to gangliosides and myelin proteins in Guillain-Barré syndrome. Annals of Neurology, 27(Sup. 1), S48-S52. (doi:10.1002/ana.410270713)

1988

Willison, H.J., Trapp, B.D., Bacher, J.D., Dalakas, M.C., Griffin, J.W., and Quarles, R.H. (1988) Demyelination induced by intraneural injection of human antimyelin-associated glycoprotein antibodies. Muscle and Nerve, 11(11), pp. 1169-1176. (doi:10.1002/mus.880111111)

Ilyas, A.A., Willison, H.J., Dalakas, M.C., Whitaker, J.N., and Quarles, R.H. (1988) Identification and characterization of gangliosides reacting with IgM paraproteins in three patients with neuropathy associated with biclonal gammopathy. Journal of Neurochemistry, 51(3), pp. 851-858. (doi:10.1111/j.1471-4159.1988.tb01821.x)

Ilyas, A.A., Willison, H.J., Quarles, R.H., Jungalwala, F.B., Cornblath, D.R., Trapp, B.D., Griffin, D.E., Griffin, J.W., and McKhann, G.M. (1988) Serum antibodies to gangliosides in Guillain-Barré syndrome. Annals of Neurology, 23(5), pp. 440-447. (doi:10.1002/ana.410230503)

Willison, H.J., Trapp, B.D., Bacher, J.D., and Quarles, R.H. (1988) The expression of myelin-associated glycoprotein in regenerating cat sciatic nerve. Brain Research, 444(1), pp. 10-16. (doi:10.1016/0006-8993(88)90907-9)

1987

Willison, H.J., Ilyas, A.I., O'Shannessy, D.J., Pulley, M., Trapp, B.D., and Quarles, R.H. (1987) Myelin-associated glycoprotein and related glycoconjugates in developing cat peripheral nerve: a correlative biochemical and morphometric study. Journal of Neurochemistry, 49(6), pp. 1853-1862. (doi:10.1111/j.1471-4159.1987.tb02447.x)

1986

Quarles, R.H., Ilyas, A.A., and Willison, H.J. (1986) Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system. Chemistry and Physics of Lipids, 42(1-3), pp. 235-248. (doi:10.1016/0009-3084(86)90055-1)

Ilyas, A.A., Dobersen, M.J., Willison, H.J., and Quarles, R.H. (1986) Mouse monoclonal and rabbit polyclonal antibodies prepared to human myelin-associated glycoprotein also react with glycosphingolipids of peripheral nerve. Journal of Neuroimmunology, 12(2), pp. 99-106. (doi:10.1016/0165-5728(86)90023-8)

Willison, H.J., Minna, J.D., Brady, R.O., and Quarles, R.H. (1986) Glycoconjugates in nervous tissue and small cell lung cancer share immunologically cross-reactive carbohydrate determinants. Journal of Neuroimmunology, 10(4), pp. 353-365. (doi:10.1016/S0165-5728(86)90018-4)

1985

Willison, H.J., Muller, D.P., Matthews, S., Jones, S., Kriss, A., Stead, R.J., Hodson, M.E., and Harding, A.E. (1985) A study of the relationship between neurological function and serum vitamin E concentrations in patients with cystic fibrosis. Journal of Neurology, Neurosurgery and Psychiatry, 48(11), pp. 1097-1102.

O'Shannessy, D.J., Willison, H.J., Inuzuka, T., Dobersen, M.J., and Quarles, R.H. (1985) The species distribution of nervous system antigens that react with anti-myelin-associated glycoprotein antibodies. Journal of Neuroimmunology, 9(5), pp. 255-268. (doi:10.1016/S0165-5728(85)80024-2)

1982

Harding, A.E., Muller, D.P., Thomas, P.K., and Willison, H.J. (1982) Spinocerebellar degeneration secondary to chronic intestinal malabsorption: a vitamin E deficiency syndrome. Annals of Neurology, 12(5), pp. 419-424.

This list was generated on Sun Aug 2 23:25:21 2015 BST.
Jump to: Articles
Number of items: 166.

Articles

Delmont, E., Halstead, S., Galban-Horcajo, F., Yao, D., Desnuelle, C., and Willison, H. (2015) Improving the detection of IgM antibodies against glycolipids complexes of GM1 and galactocerebroside in multifocal motor neuropathy using glycoarray and ELISA assays. Journal of Neuroimmunology, 278, pp. 159-161. (doi:10.1016/j.jneuroim.2014.11.001) (PMID:25468269)

Galban-Horcajo, F., Halstead, S. K., McGonigal, R., and Willison, H. J. (2014) The application of glycosphingolipid arrays to autoantibody detection in neuroimmunological disorders. Current Opinion in Chemical Biology, 18, pp. 78-86. (doi:10.1016/j.cbpa.2014.01.008)

Fewou, S.N., Plomp, J.J., and Willison, H.J. (2014) The pre-synaptic motor nerve terminal as a site for antibody-mediated neurotoxicity in autoimmune neuropathies and synaptopathies. Journal of Anatomy, 224(1), pp. 36-44. (doi:10.1111/joa.12088)

Willison, H. J., Galban-Horcajo, F., and Halstead, S. K. (2014) Antibodies to GM1: galactocerebroside complexes in multifocal motor neuropathy: it takes two to tango. Journal of Neurology, Neurosurgery and Psychiatry, 85(7), p. 715. (doi:10.1136/jnnp-2013-306050)

Yao, D. et al. (2014) Neuronal expression of galnac transferase is sufficient to prevent the age-related neurodegenerative phenotype of complex ganglioside-deficient mice. Journal of Neuroscience, 34(3), pp. 880-891. (doi:10.1523/JNEUROSCI.3996-13.2014)

Reindl, M. et al. (2013) Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome. PLoS ONE, 8(12), e82337. (doi:10.1371/journal.pone.0082337)

Willison, H.J., and Goodyear, C.S. (2013) Glycolipid antigens and autoantibodies in autoimmune neuropathies. Trends in Immunology, 34(9), pp. 453-459. (doi:10.1016/j.it.2013.05.001)

Rupp, A., Cunningham, M.E., Yao, D., Furukawa, K., and Willison, H.J. (2013) The effects of age and ganglioside composition on the rate of motor nerve terminal regeneration following antibody-mediated injury in mice. Synapse, 67(7), pp. 382-389. (doi:10.1002/syn.21648)

Rupp, A.F., Galban-Horcajo, F., Bianchi, E., Dondi, M., Penderis, J., Cappell, J., Burgess, K., Matiasek, K., McGonigal, R., and Willison, H.J. (2013) Anti-GM2 ganglioside antibodies are a biomarker for acute canine polyradiculoneuritis. Journal of the Peripheral Nervous System, 18(1), pp. 75-88. (doi:10.1111/jns5.12011)

Galban-Horcajo, F., Fitzpatrick, A.M., Hutton, A.J., Dunn, S.M., Kalna, G., Brennan, K.M., Rinaldi, S., Yu, R.K., Goodyear, C.S., and Willison, H.J. (2013) Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy. European Journal of Neurology, 20(1), pp. 62-70. (doi:10.1111/j.1468-1331.2012.03767.x)

Chavada, G., and Willison, H.J. (2012) Autoantibodies in immune-mediated neuropathies. Current Opinion in Neurology, 25(5), pp. 550-555. (doi:10.1097/WCO.0b013e328357a77f)

Willison, H.J., and Linington, C. (2012) Antibodies to MOG in NMO: a seasoned veteran finds a new role. Neurology, 79(12), pp. 1198-1199. (doi:10.1212/WNL.0b013e31826aadaf)

Elliott, C. et al. (2012) Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis. Brain, 135(6), pp. 1819-1833. (doi:10.1093/brain/aws105)

Fewou, S.N., Rupp, A., Nickolay, L.E., Carrick, K., Greenshields, K.N., Pediani, J., Plomp, J.J., and Willison, H.J. (2012) Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy. Journal of Clinical Investigation, 122(3), pp. 1037-1051. (doi:10.1172/JCI59110)

Huizinga, R. et al. (2012) Sialylation of campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice. PLoS ONE, 7(3), e34416. (doi:10.1371/journal.pone.0034416) (PMID:22470569) (PMCID:PMC3314637)

Islam, Z. et al. (2012) Guillain-Barré Syndrome-related campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies. PLoS ONE, 7(8), e43976. (doi:10.1371/journal.pone.0043976)

Rinaldi, S., Brennan, K.M., and Willison, H.J. (2012) Combinatorial glycoarray. Methods in Molecular Biology, 808, pp. 413-423. (doi:10.1007/978-1-61779-373-8_28)

Rupp, A., Morrison, I., Barrie, J.A., Halstead, S.K., Townson, K.H., Greenshields, K.N., and Willison, H.J. (2012) Motor nerve terminal destruction and regeneration following anti-ganglioside antibody and complement-mediated injury: An in and ex vivo imaging study in the mouse. Experimental Neurology, 233(2), pp. 836-848. (doi:10.1016/j.expneurol.2011.12.010)

Höke, A., and Willison, H.J. (2011) In memoriam: remembering John W. 'Jack' Griffin M.D. Nature Reviews Neurology, 7, pp. 361-362. (doi:10.1038/nrneurol.2011.94)

Barnett, M. H., Barnett, Y., Burke, D., and Willison, H. (2011) Spinal nerve root hypertrophy in chronic ataxic neuropathy with antiglycolipid IgM antibodies. Journal of Neurology, Neurosurgery and Psychiatry, 82(1), p. 97. (doi:10.1136/jnnp.2010.205096)

Brennan, K.M. et al. (2011) Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis. Journal of Neuroimmunology, 238(1-2), pp. 87-95. (doi:10.1016/j.jneuroim.2011.08.002)

Fitzpatrick, A.M., Mann, C.A., Barry, S., Brennan, K., Overell, J.R., and Willison, H.J. (2011) An open label clinical trial of complement inhibition in multifocal motor neuropathy. Journal of the Peripheral Nervous System, 16(2), pp. 84-91. (doi:10.1111/j.1529-8027.2011.00328.x)

Hartung, H.-P., Lehmann, H.C., and Willison, H.J. (2011) Peripheral neuropathies: Establishing common clinical research standards for CIDP. Nature Reviews Neurology, 7(5), pp. 250-251. (doi:10.1038/nrneurol.2011.46)

Nilsson, E.C. et al. (2011) The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis. Nature Medicine, 17(1), pp. 105-109. (doi:10.1038/nm.2267)

Willison, H. (2011) Reply: Neurofascin as target of autoantibodies in Guillain-Barre syndrome. Brain, 134(5), e174-e174. (doi:10.1093/brain/awq375)

Willison, H.J. (2011) Biomarkers in experimental models of antibody-mediated neuropathies. Journal of the Peripheral Nervous System, 16, pp. 60-62. (doi:10.1111/j.1529-8027.2011.00310.x)

Zitman, F.M.P. et al. (2011) Neuropathophysiological potential of Guillain-Barré syndrome anti-ganglioside-complex antibodies at mouse motor nerve terminals. Clinical and Experimental Neuroimmunology, 2(3), pp. 59-67. (doi:10.1111/j.1759-1961.2011.00022.x)

Zitman, F.M.P., Todorov, B., Verschuuren, J.J., Jacobs, B.C., Furukawa, K., Furukawa, K., Willison, H.J., and Plomp, J.J. (2011) Neuromuscular synaptic transmission in aged ganglioside-deficient mice. Neurobiology of Aging, 32(1), pp. 157-167. (doi:10.1016/j.neurobiolaging.2009.01.007)

McGonigal, R., Rowan, E.G., Greenshields, K.N., Halstead, S.K., Humphreys, P.D., Rother, R.P., Furukawa, K., and Willison, H.J. (2010) Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice. Brain, 133(7), pp. 1944-1960. (doi:10.1093/brain/awq119)

Willison, H.J. (2010) Sugar refining reveals a further specificity for autoantibodies in multifocal motor neuropathy. Journal of Neurology, Neurosurgery and Psychiatry, 81(7), pp. 707-708. (doi:10.1136/jnnp.2010.205310)

Zitman, F.M.P., Todorov, B., Furukawa, K., Furukawa, K., Willison, H.J., and Plomp, J.J. (2010) Total ganglioside ablation at mouse motor nerve terminals alters neurotransmitter release level. Synapse, 64(4), pp. 335-338. (doi:10.1002/syn.20747)

Willison, H.J., and Wraith, D.C. (2010) A hazardous vapour trail from abattoir to neuropathy clinic. Lancet Neurology, 9(1), pp. 22-24. (doi:10.1016/S1474-4422(09)70323-0)

Lockington, D., Imrie, F., Gillen, J., Fitzpatrick, A., and Willison, H. (2010) Visual improvement in established central retinal vein occlusion with long standing macular edema following systemic eculizumab treatment. Canadian Journal of Ophthalmology = Journal canadien d'ophtalmologie, 45(6), p. 649. (doi:10.3129/i10-060)

Rinaldi, S., Brennan, K.M., and Willison, H.J. (2010) Heteromeric glycolipid complexes as modulators of autoantibody and lectin binding. Progress in Lipid Research, 49(1), pp. 87-95. (doi:10.1016/j.plipres.2009.09.001)

Jacobs, B.C., and Willison, H.J. (2009) Peripheral neuropathies: biomarkers for axonal damage in immune-mediated neuropathy. Nature Reviews Neurology, 5(11), pp. 584-585. (doi:10.1038/nrneurol.2009.161)

Reid, J.M., Foley, P., and Willison, H.J. (2009) Voltage-gated potassium channel-associated limbic encephalitis in the west of Scotland: case reports and literature review. Scottish Medical Journal, 54(4), pp. 27-31. (doi:10.1258/rsmsmj.54.4.27)

Plomp, J.J., and Willison, H.J. (2009) Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction. Journal of Physiology, 587(16), pp. 3979-3999. (doi:10.1113/jphysiol.2009.171702)

Iorio, R., Capone, F., Iannaccone, E., Willison, H.J., Modoni, A., Tonali, P.A., and Silvestri, G. (2009) SIADH in a patient with sensory ataxic neuropathy with anti-disialosyl antibodies (CANOMAD). Journal of Neurology, 256(7), pp. 1177-1179. (doi:10.1007/s00415-009-5071-0)

Greenshields, K.N. et al. (2009) The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice. Journal of Clinical Investigation, 119(3), pp. 595-610. (doi:10.1172/JCI37338)

Liu, J., Willison, H., and Pedrosa-Domellof, F. (2009) Immunolocalization of GQ1b and Related Gangliosides in Human Extraocular Neuromuscular Junctions and Muscle Spindles. Investigative Ophthalmology and Visual Science, 50(7), pp. 3226-3232.

Lunn, M.P.T., and Willison, H.J. (2009) Diagnosis and treatment in inflammatory neuropathies. Journal of Neurology, Neurosurgery and Psychiatry, 80(3), pp. 249-258.

Lunn, M., and Willison, H. (2009) Diagnosis and treatment in inflammatory neuropathies (Reprinted from Journal of Neurology, Neurosurgery, and Psychiatry, vol 80, pg 249-58, 2009). Postgraduate Medical Journal, 85(1006), pp. 437-446.

Marioni, R. et al. (2009) Peripheral Levels of Fibrinogen, C-Reactive Protein, and Plasma Viscosity Predict Future Cognitive Decline in Individuals Without DementiaPeripheral Neuropathies Biomarkers for Axonal Damage in Immune-Mediated Neuropathy. Psychosomatic Medicine, 71(8), pp. 901-906.

Rinaldi, S., Brennan, K., Goodyear, C., O'Leary, C., Schiavo, G., Crocker, P., and Willison, H. (2009) Analysis of lectin binding to glycolipid complexes using combinatorial glycoarrays. Glycobiology, 19(7), pp. 789-796. (doi:10.1093/glycob/cwp049)

Silajdzic, E., Willison, H., Furukawa, K., and Barnett, S. (2009) In Vitro Analysis of Glial Cell Function in Ganglioside-deficient Mice. Journal of Neuroscience Research, 87(11), pp. 2467-2483. (doi:10.1002/jnr.22085 )

Halstead, S., Zitman, F., Humphreys, P., Greenshields, K., Verschuuren, J., Jacobs, B., Rother, R., Plomp, J., and Willison, H. (2008) Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain, 131(5), pp. 1197-1208. (doi:10.1093/brain/awm316 )

Court, F., Gillingwater, T., Melrose, S., Sherman, D., Greenshields, K., Morton, A., Harris, J., Willison, H., and Ribchester, R. (2008) Identity, developmental restriction and reactivity of extralaminar cells capping mammalian neuromuscular junctions. Journal of Cell Science, 121(23), pp. 3901-3911.

Halstead, S., Humphreys, P., Zitman, F., Hamer, J., Plomp, J., and Willison, H. (2008) C5 inhibitor rEV576 protects against neural injury in an in vitro mouse model of Miller Fisher syndrome. Journal of the Peripheral Nervous System, 13(3), pp. 228-235.

Jacobs, B., Koga, M., van Rijs, W., Geleijns, K., van Doom, P., Willison, H., and Yuki, N. (2008) Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barre syndrome. Journal of Neuroimmunology, 194(1-2), pp. 181-190.

Rinaldi, S., and Willison, H. (2008) Ganglioside antibodies and neuropathies. Current Opinion in Neurology, 21(5), pp. 540-546.

Townson, K., Speak, A., Greenshields, K., Goodyear, C., Willison, H., and Platt, F. (2008) Glycosphingolipid depletion in PC12 cells using iminosugars protects neuronal membranes from anti-ganglioside antibody mediated injury. Journal of Neuroimmunology, 203(1), pp. 33-38. (doi:10.1016/j.jneuroim.2008.06.033)

Willison, H., Halstead, S., Bevenidge, E., Zitman, F., Greenshields, K., Morgan, B., and Plomp, J. (2008) The role of complement and complement regulators in mediating motor nerve terminal injury in murine models of Guillain-Barre syndrome. Journal of Neuroimmunology, 201, pp. 172-182.

Willison, H., and Plomp, J. (2008) Anti-ganglioside antibodies and the presynaptic motor nerve terminal. Myasthenia Gravis and Related Disorders, 1132, pp. 114-123.

Zitman, F.M.P., Todorov, B., Jacobs, B.C., Verschuuren, J.J., Furukawa, K., Willison, H.J., and Plomp, J.J. (2008) Neuromuscular synaptic function in mice lacking major subsets of gangliosides. Neuroscience, 156(4), pp. 885-897. (doi:10.1016/j.neuroscience.2008.08.034)

Willison, H.J. (2007) Gangliosides as targets for autoimmune injury to the nervous system. Journal of Neurochemistry, 103(s1), pp. 143-149. (doi:10.1111/j.1471-4159.2007.04718.x)

Nachamkin, I. et al. (2007) Patterns of Guillain-Barre syndrome in children - Results from a Mexican population. Neurology, 69, pp. 1665-1671.

Overell, J.R., Hsieh, S.-T., Odaka, M., Yuki, N., and Willison, H.J. (2007) Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders. Cochrane Database of Systematic Reviews(1), CD004761. (doi:10.1002/14651858.CD004761.pub2)

Townson, K. et al. (2007) Solid phase immunoadsorption for therapeutic and analytical studies on neuropathy-associated anti-GM1 antibodies. Glycobiology, 17, pp. 294-303. (doi:10.1093/glycob/cwl074)

Townson, K. et al. (2007) Sulfatide binding properties of murine and human antiganglioside antibodies. Glycobiology, 17, pp. 1156-1166. (doi:10.1093/glycob/cwm095)

Willison, H.J. (2006) Ganglioside complexes as targets for antibodies in Miller Fisher syndrome. Journal of Neurology, Neurosurgery and Psychiatry, 77(9), pp. 1002-1003. (doi:10.1136/jnnp.2006.094441)

Deinhardt, K., Berninghausen, O., Willison, H.J., Hopkins, C.R., and Schiavo, G. (2006) Tetanus toxin is internalized by a sequential clathrin-dependent mechanism initiated within lipid microdomains and independent of epsin1. Journal of Cell Biology, 174(3), pp. 459-71. (doi:10.1083/jcb.200508170)

Avril, T., North, S., Haslam, S., Willison, H., and Crocker, P. (2006) Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha 2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha 2,8-sialyltransferase gene expression. Journal of Leukocyte Biology, 80, pp. 787-796. (doi:10.1189/jlb.1005559)

Avril, T., Wagner, E., Willison, H., and Crocker, P. (2006) Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides. Infection and Immunity, 74, pp. 4133-4141. (doi:10.1128/IAI.02094-05)

Willison, H.J. (2006) Basic and clinical aspects of autoimmune disorders in peripheral nerves. Acta Neurologica Scandinavica, 113(s183), pp. 14-18. (doi:10.1111/j.1600-0404.2006.00607.x)

Halstead, S.K., Morrison, I., O'Hanlon, G.M., Humphreys, P.D., Goodfellow, J.A., Plomp, J.J., and Willison, H.J. (2005) Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions. Glia, 52(3), pp. 177-189. (doi:10.1002/glia.20228)

Willison, H.J. (2005) Ganglioside complexes: new autoantibody targets in Guillain-Barré syndromes. Nature Clinical Practice Neurology, 1(1), pp. 2-3. (doi:10.1038/ncpneuro0001)

Boffey, J., Odaka, M., Nicoll, D., Wagner, E.R., Townson, K., Bowes, T., Conner, J., Furukawa, K., and Willison, H.J. (2005) Characterisation of the immunoglobulin variable region gene usage encoding the murine anti-ganglioside antibody repertoire. Journal of Neuroimmunology, 165(1-2), pp. 92-103. (doi:10.1016/j.jneuroim.2005.04.011)

Willison, H.J. (2005) The immunobiology of Guillain-Barré syndromes. Journal of the Peripheral Nervous System, 10(2), pp. 94-112. (doi:10.1111/j.1085-9489.2005.0010202.x)

Bullens, R., Halstead, S., OHanlon, G., Veitch, J., Molenaar, P., Willison, H., and Plomp, J. (2005) Concanavalin A inhibits pathophysiological effects of anti-ganglioside GQ1b antibodies at the mouse neuromuscular synapse. Muscle and Nerve, 31, pp. 751-760. (doi:10.1002/mus.20327)

Goodfellow, J. et al. (2005) Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy. Journal of Neuroscience, 25, pp. 1620-1628. (doi:10.1523/JNEUROSCI.4279-04.2005)

Halstead, S., Humphreys, P., Goodfellow, J., Wagner, E., Smith, R., and Willison, H. (2005) Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome. Annals of Neurology, 58, pp. 203-210. (doi:10.1002/ana.20546)

Overell, J., and Willison, H. (2005) Recent developments in Miller Fisher syndrome and related disorders. Current Opinion in Neurology, 18, pp. 562-566.

Lee, G., Jeong, Y., Wirguin, I., Hays, A.P., Willison, H.J., and Latov, N. (2004) Induction of human IgM and IgG anti-GM1 antibodies in transgenic mice in response to lipopolysaccharides from Campylobacter jejuni. Journal of Neuroimmunology, 146(1-2), pp. 63-75. (doi:10.1016/j.jneuroim.2003.10.045)

Andersen, S., Ling, C., Zhang, P., Townson, K., Willison, H., and Bundle, D. (2004) Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barre syndrome. Organic and Biomolecular Chemistry, 2, pp. 1199-1212. (doi:10.1039/b400029c)

Boffey, J., Nicholl, D., Wagner, E., Townson, K., Goodyear, C., Furukawa, K., Conner, J., and Willison, H. (2004) Innate murine B cells produce anti-disialosyl antibodies reactive with Campylobacter jejuni LPS and gangliosides that are polyreactive and encoded by a restricted set of unmutated V genes. Journal of Neuroimmunology, 152, pp. 98-111. (doi:10.1016/j.jneuroim.2004.04.002)

Halstead, S., OHanlon, G., Humphreys, P., Morrison, D., Morgan, B., Todd, A., Plomp, J., and Willison, H. (2004) Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain, 127, pp. 2109-2123. (doi:10.1093/brain/awh231)

Kieseier, B.C., Kiefer, R., Gold, R., Hemmer, B., Willison, H.J., and Hartung, H.P. (2004) Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle and Nerve, 30, pp. 131-156. (doi:10.1002/mus.20076)

Willison, H., Townson, K., Veitch, J., Boffey, J., Isaacs, N., Andersen, S., Zhang, P., Ling, C., and Bundle, D. (2004) Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune nueropathy sera. Brain, 127, pp. 680-691. (doi:10.1093/brain/awh083)

O'Hanlon, G.M., Hirst, T.R., and Willison, H.J. (2003) Ganglioside GM1 binding toxins and human neuropathy-associated IgM antibodies differentially promote neuritogenesis in a PC12 assay. Neuroscience Research, 47(4), pp. 383-390. (doi:10.1016/S0168-0102(03)00239-6)

Jacobs, B.C., O'Hanlon, G.M., Bullens, R.W.M., Veitch, J., Plomp, J.J., and Willison, H.J. (2003) Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding. Brain, 126(10), pp. 2220-2234. (doi:10.1093/brain/awg235)

Bullens, R.W.M., O'Hanlon, G.M., Wagner, E., Molenaar, P.C., Furukawa, K., Furukawa, K., Plomp, J.J., and Willison, H.J. (2003) Roles of complex gangliosides at the neuromuscular junction. Annals of the New York Academy of Sciences, 998(1), pp. 401-403. (doi:10.1196/annals.1254.051)

Willison, H.J., and Winer, J.B. (2003) Clinical evaluation and investigation of neuropathy. Journal of Neurology, Neurosurgery and Psychiatry, 74(s2), ii3-ii8. (doi:10.1136/jnnp.74.suppl_2.ii3)

McCrone, P. et al. (2003) Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. European Journal of Neurology, 10, pp. 687-694.

OHanlon, G., Humphreys, P., Goldman, R., Halstead, S., Bullens, R., Plomp, J., Ushkaryov, Y., and Willison, H. (2003) Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury. Brain, 126, pp. 2497-2509. (doi:10.1093/brain/awg254)

Ooi, M.H. et al. (2003) Adenovirus type 21-associated acute flaccid paralysis during an outbreak of hand-foot-and-mouth disease in Sarawak, Malaysia. Clinical Infectious Diseases, 36(5), pp. 550-559. (doi:10.1086/367648)

Pritchard, J., Gray, I., Idrissova, Z., Lecky, B., Sutton, I., Swan, A., Willison, H., Winer, J., and Hughes, R. (2003) A randomized controlled trial of recombinant interferon-beta 1a in Guillain-Barre syndrome. Neurology, 61, pp. 1282-1284.

Pritchard, J., Hughes, R.A.C., Rees, J.H., Willison, H.J., and Nicoll, J.A.R. (2003) Apolipoprotein E genotypes and clinical outcome in Guillain-Barre syndrome. Journal of Neurology, Neurosurgery and Psychiatry, 74, pp. 971-973.

Solomon, T., and Willison, H. (2003) Infectious causes of acute flaccid paralysis. Current Opinion in Infectious Diseases, 16, pp. 375-381. (doi:10.1097/01.qco.0000092807.64370.1e)

Willison, H.J. (2002) Anti-glycolipid antibodies in the diagnosis of autoimmune neuropathies. Revue Neurologique, 158(123), pp. 16-20.

Willison, H.J., and Yuki, N. (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain, 125(12), pp. 2591-2625. (doi:10.1093/brain/awf272)

Hartung, H.-P., Willison, H.J., and Kieseier, B.C. (2002) Acute immunoinflammatory neuropathy: update on Guillain-Barré syndrome. Current Opinion in Neurology, 15(5), pp. 571-577.

Bowes, T., Wagner, E.R., Boffey, J., Nicholl, D., Cochrane, L., Benboubetra, M., Conner, J., Furukawa, K., Furukawa, K., and Willison, H.J. (2002) Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome. Infection and Immunity, 70(9), pp. 5008-5018. (doi:10.1128/IAI.70.9.5008-5018.2002)

Bullens, R.W.M., O'Hanlon, G.M., Wagner, E., Molenaar, P.C., Furukawa, K., Furukawa, K., Plomp, J.J., and Willison, H.J. (2002) Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function. Journal of Neuroscience, 22(16), pp. 6876-6884.

O'Hanlon, G.M., Bullens, R.W.M., Plomp, J.J., and Willison, H.J. (2002) Complex gangliosides as autoantibody targets at the neuromuscular junction in Miller Fisher syndrome: a current perspective. Neurochemical Research, 27(7-8), pp. 697-709. (doi:10.1023/A:1020284302718)

Jacobs, B.C., Bullens, R.W.M., O'Hanlon, G.M., Ang, C.W., Willison, H.J., and Plomp, J.J. (2002) Detection and prevalence of α-latrotoxin-like effects of serum from patients with Guillain-Barré syndrome. Muscle and Nerve, 25(4), pp. 549-558. (doi:10.1002/mus.10060)

Ang, C.W., Laman, J.D., Willison, H.J., Wagner, E.R., Endtz, H.P., De Klerk, M.A., Tio-Gillen, A.P., Van den Braak, N., Jacobs, B.C., and Van Doorn, P.A. (2002) Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. Infection and Immunity, 70(3), pp. 1202-1208. (doi:10.1128/IAI.70.3.1202-1208.2002)

Willison, H.J., Stoll, G., Toyka, K.V., Berger, T., and Hartung, H.-P. (2002) Autoimmunity and inflammation in the peripheral nervous system. Trends in Neurosciences, 25(3), pp. 127-129. (doi:10.1016/S0166-2236(00)02120-2)

Comi, G. et al. (2002) A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. Journal of Neurology, 249, pp. 1370-1377. (doi:10.1007/s00415-002-0808-z)

Willison, H.J. (2001) Fine specificity of anti-GQ1b antibodies and clinical features. Journal of the Neurological Sciences, 185(1), pp. 1-2. (doi:10.1016/S0022-510X(01)00465-8)

Serrano-Munuera, C. et al. (2001) Antiganglioside antibodies in acute self-limiting ataxic neuropathy: incidence and significance. Journal of Neuroimmunology, 120(1-2), pp. 78-83. (doi:10.1016/S0165-5728(01)00428-3)

Hadden, R., Gregson, N., Gold, R., Willison, H., and Hughes, R. (2001) Guillain-Barre syndrome serum and anti-Campylobacter antibody do not exacerbate experimental autoimmune neuritis. Journal of Neuroimmunology, 119, pp. 306-316.

Hughes, R. et al. (2001) Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Annals of Neurology, 50, pp. 195-201.

O'Hanlon, G.M. et al. (2001) Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain, 124(5), pp. 893-906. (doi:10.1093/brain/124.5.893)

Willison, H. et al. (2001) The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain, 124, pp. 1968-1977.

Willison, H.J., Ang, W., Gilhus, N.E., Graus, F., Liblau, R., Vedeler, C., and Vincent, A. (2000) EFNS task force report: a questionnaire-based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres. European Journal of Neurology, 7(6), pp. 625-628. (doi:10.1046/j.1468-1331.2000.00158.x)

O'Leary, C.P., and Willison, H.J. (2000) The role of antiglycolipid antibodies in peripheral neuropathies. Current Opinion in Neurology, 13(5), pp. 583-588.

Bensa, S., Hadden, R.D.M., Hahn, A., Hughes, R.A.C., and Willison, H.J. (2000) Randomized controlled trial of brain-derived neurotrophic factor in Guillain-Barré syndrome: a pilot study. European Journal of Neurology, 7(4), pp. 423-426. (doi:10.1046/j.1468-1331.2000.00096.x)

Bullens, R.W.M., O'Hanlon, G.M., Goodyear, C.S., Molenaar, P.C., Conner, J., Willison, H.J., and Plomp, J.J. (2000) Anti-GQ1b antibodies and evoked acetylcholine release at mouse motor endplates. Muscle and Nerve, 23(7), pp. 1035-1043. (doi:10.1002/1097-4598(200007)23:7<1035::AID-MUS5>3.0.CO;2-R)

Lough, J.C., Rafferty, D., McColl, J.H., Bell, F., and Willison, H.J. (2000) The application of control limits analysis to the myometric assessment of motor performance in neuropathy patients. European Journal of Neurology, 7(4), pp. 427-434. (doi:10.1046/j.1468-1331.2000.00095.x)

Ponsford, S., Willison, H.J., Veitch, J., Morris, R., and Thomas, P.K. (2000) Long-term clinical and neurophysiological follow-up of patients with peripheral, neuropathy associated with benign monoclonal gammopathy. Muscle and Nerve, 23(2), pp. 164-174. (doi:10.1002/(SICI)1097-4598(200002)23:2<164::AID-MUS4>3.0.CO;2-Y)

O'Hanlon, G.M., Veitch, J., Gallardo, E., Illa, I., Chancellor, A.M., and Willison, H.J. (2000) Peripheral neuropathy associated with anti-GM2 ganglioside antibodies: clinical and immunopathological studies. Autoimmunity, 32(2), pp. 133-144.

Willison, H.J., and O'Hanlon, G.M. (1999) The immunopathogenesis of Miller Fisher syndrome. Journal of Neuroimmunology, 100(1-2), pp. 3-12. (doi:10.1016/S0165-5728(99)00213-1)

Goodyear, C.S., O'Hanlon, G.M., Plomp, J.J., Wagner, E.R., Cochrane, L., Bullens, R.W.M., Molenaar, P.C., Conner, J., and Willison, H.J. (1999) Monoclonal antibodies raised against Guillain-Barr. Journal of Clinical Investigation, 104(6), pp. 697-708. (doi:10.1172/JCI6837)

Prendergast, M.M., Willison, H.J., and Moran, A.P. (1999) Human monoclonal immunoglobulin M antibodies to ganglioside GM1 show diverse cross-reactivities with lipopolysaccharides of Campylobacter jejuni strains associated with Guillain-Barré syndrome. Infection and Immunity, 67(7), pp. 3698-3701.

Paparounas, K., O'Hanlon, G.M., O'Leary, C.P., Rowan, E.G., and Willison, H.J. (1999) Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro. Brain, 122(5), pp. 807-816. (doi:10.1093/brain/122.5.807)

Ballantyne, J.P. et al. (1999) Management of drug budgets: neurologists do not have confidence in Glasgow's method of managing drugs budget. British Medical Journal, 318(7187), p. 874. (doi:10.1136/bmj.318.7187.874)

Weiss, M.D., Dalakas, M.C., Lauter, C.J., Willison, H.J., and Quarles, R.H. (1999) Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinemia. Journal of Neuroimmunology, 95(1-2), pp. 174-184. (doi:10.1016/S0165-5728(98)00247-1)

Ho, T.W. et al. (1999) Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Annals of Neurology, 45(2), pp. 168-173. (doi:10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6)

Benatar, M., Willison, H.J., and Vincent, A. (1999) Immune-mediated peripheral neuropathies and voltage-gated sodiums channels. Muscle and Nerve, 22(1), pp. 108-110. (doi:10.1002/(SICI)1097-4598(199901)22:1<108::AID-MUS16>3.0.CO;2-I)

Willison, H.J., Veitch, J., Swan, A.V., Baumann, N., Comi, G., Gregson, N.A., Illa, I., Zielasek, J., and Hughes, R.A.C. (1999) Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies. European Journal of Neurology, 6(1), pp. 71-77. (doi:10.1046/j.1468-1331.1999.610071.x)

Sheikh, K.A. et al. (1998) Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility. Neurology, 51(2), pp. 371-378.

O'Hanlon, G.M., Paterson, G.J., Veitch, J., Wilson, G., and Willison, H.J. (1998) Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies. Acta Neuropathologica, 95(6), pp. 605-616.

Benatar, M.G., Willison, H.J., and Vincent, A. (1997) Lack of effect of Miller Fisher sera/plasmas on transmitter release from PC12 cells. Journal of Neuroimmunology, 80(1-2), pp. 1-5. (doi:10.1016/S0165-5728(97)00127-6)

Jacobs, B.C., O'Hanlon, G.M., Breedland, E.G., Veitch, J., van Doorn, P.A., and Willison, H.J. (1997) Human IgM paraproteins demonstrate shared reactivity between Campylobacter jejuni lipopolysaccharides and human peripheral nerve disialylated gangliosides. Journal of Neuroimmunology, 80(1-2), pp. 23-30. (doi:10.1016/S0165-5728(97)00130-6 )

Willison, H.J., O'Hanlon, G.M., Paterson, G., O'Leary, C.P., Veitch, J., Wilson, G., Roberts, M., Tang, T., and Vincent, A. (1997) Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome. Journal of Infectious Diseases, 176(s2), s144-s149. (doi:10.1086/513799)

O'Leary, C.P., and Willison, H.J. (1997) Autoimmune ataxic neuropathies (sensory ganglionopathies). Current Opinion in Neurology, 10(5), pp. 366-370.

O'Leary, C.P., Mann, A.C., Lough, J., and Willison, H.J. (1997) Muscle hypertrophy in multifocal motor neuropathy is associated with continuous motor unit activity. Muscle and Nerve, 20(4), pp. 479-485. (doi:10.1002/(SICI)1097-4598(199704)20:4<479::AID-MUS11>3.0.CO;2-U)

Ho, T.W. et al. (1997) Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology, 48(3), pp. 717-724.

Willison, H.J., O'Hanlon, G.M., Paterson, G., Veitch, J., Wilson, G., Roberts, M., Tang, T., and Vincent, A. (1996) A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18. Journal of Clinical Investigation, 97(5), pp. 1155-1164.

O'Hanlon, G.M., Paterson, G.J., Wilson, G., Doyle, D., McHardie, P., and Willison, H.J. (1996) Anti-GM1 ganglioside antibodies cloned from autoimmune neuropathy patients show diverse binding patterns in the rodent nervous system. Journal of Neuropathology and Experimental Neurology , 55(2), pp. 184-195.

Jamieson, D.R., Teasdale, E., and Willison, H.J. (1996) False localising signs in the spinal cord. British Medical Journal, 312(7025), pp. 243-244.

Hartung, H.-P., Willison, H.J., Jung, S., Pette, M., Toyka, K.V., and Giegerich, G. (1996) Autoimmune responses in peripheral nerve. Springer Seminars in Immunopathology, 18(1), pp. 97-123. (doi:10.1007/BF00792612)

O'Leary, C.P., and Willison, H.J. (1995) Immunological investigation. Current Opinion in Neurology, 8(5), pp. 349-353.

Paterson, G., Wilson, G., Kennedy, P.G., and Willison, H.J. (1995) Analysis of anti-GM1 ganglioside IgM antibodies cloned from motor neuropathy patients demonstrates diverse V region gene usage with extensive somatic mutation. Journal of Immunology, 155(6), pp. 3049-3059.

Roberts, M., Willison, H.J., Vincent, A., and Newsom-Davis, J. (1995) Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Annals of Neurology, 38(1), pp. 111-118. (doi:10.1002/ana.410380118)

Vincent, A., Roberts, M., Willison, H.J., Lang, B., and Newsom-Davis, J. (1995) Autoantibodies, neurotoxins and the nervous system. Journal of Physiology: Paris, 89(3), pp. 129-136. (doi:10.1016/0928-4257(96)80110-0)

Willison, H.J., Almemar, A., Veitch, J., and Thrush, D. (1994) Acute ataxic neuropathy with cross-reactive antibodies to GD1b and GD3 gangliosides. Neurology, 44(12), pp. 2395-2397.

Willison, H.J. (1994) Antiglycolipid antibodies in peripheral neuropathy: fact or fiction? Journal of Neurology, Neurosurgery and Psychiatry, 57(11), pp. 1303-1307. (doi:10.1136/jnnp.57.11.1303)

Willison, H.J., Chancellor, A.M., Veitch, J., Kennedy, P.G., and Warlow, C.P. (1994) Immunoglobulin G subclasses are normal in motor neuron disease. Journal of the Neurological Sciences, 124(1), pp. 115-116. (doi:10.1016/0022-510X(94)90021-3)

Vincent, A., Barrett-Jolley, R., Shillito, P., Hart, I., Beeson, D., MacLennan, C., Nicolle, M., Lang, B., Roberts, M., and Willison, H.J. (1994) Involvement of cation channels in autoimmune disease. Biochemical Society Transactions, 22(2), pp. 488-491.

Thomas, P.K., and Willison, H.J. (1994) Paraproteinaemic neuropathy. Baillière's Clinical Neurology, 3(1), pp. 129-147.

Willison, H.J., Paterson, G., Kennedy, P.G., and Veitch, J. (1994) Cloning of human anti-GM1 antibodies from motor neuropathy patients. Annals of Neurology, 35(4), pp. 471-478. (doi:10.1002/ana.410350416)

Willison, H.J., and Veitch, J. (1994) Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. Journal of Neuroimmunology, 50(2), pp. 159-165. (doi:10.1016/0165-5728(94)90042-6)

Roberts, M., Vincent, A., Newsom-Davis, J., and Willison, H.J. (1994) Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet, 343(8895), pp. 454-5. (doi:10.1016/S0140-6736(94)92694-8)

de Silva, R.N., Willison, H.J., Doyle, D., Weir, A.I., Hadley, D.M., and Thomas, A.M. (1994) Nerve root hypertrophy in chronic inflammatory demyelinating polyneuropathy. Muscle and Nerve, 17(2), pp. 168-170. (doi:10.1002/mus.880170206)

Herron, B., Willison, H.J., Veitch, J., Roelcke, D., Illis, L.S., and Boulton, F.E. (1994) Monoclonal IgM cold agglutinins with anti-Pr1d specificity in a patient with peripheral neuropathy. Vox Sanguinis, 67(1), pp. 58-63. (doi:10.1111/j.1423-0410.1994.tb05039.x)

Willison, H.J., Paterson, G., Veitch, J., Inglis, G., and Barnett, S.C. (1993) Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins. Journal of Neurology, Neurosurgery and Psychiatry, 56(11), pp. 1178-1183. (doi:10.1136/jnnp.56.11.1178)

Willison, H.J., and Kennedy, P.G. (1993) Gangliosides and bacterial toxins in Guillain-Barré syndrome. Journal of Neuroimmunology, 46(1-2), pp. 105-12. (doi:10.1016/0165-5728(93)90239-U)

Willison, H.J., and Kennedy, P.G. (1993) The fine specificity of anti-GM1 antibodies. Quarterly Journal of Medicine, 86(3), pp. 216-217.

Willison, H. J., Veitch, J., Paterson, G., and Kennedy, P. G. E. (1993) Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. Journal of Neurology, Neurosurgery and Psychiatry, 56(2), pp. 204-206. (doi:10.1136/jnnp.56.2.204)

Willison, H.J., Chancellor, A.M., Paterson, G., Veitch, J., Singh, S., Whitelaw, J., Kennedy, P.G., and Warlow, C.P. (1993) Antiglycolipid antibodies, immunoglobulins and paraproteins in motor neuron disease: a population based case-control study. Journal of the Neurological Sciences, 114(2), pp. 209-215. (doi:10.1016/0022-510X(93)90300-N)

Gregson, N.A., Jones, D., Thomas, P.K., and Willison, H.J. (1991) Acute motor neuropathy with antibodies to GM1 ganglioside. Journal of Neurology, 238(8), pp. 447-451.

Willison, H.J., Gale, A.N., and McLaughlin, J.E. (1991) Creutzfeldt-Jacob disease following cadaveric dura mater graft. Journal of Neurology, Neurosurgery and Psychiatry, 54(10), p. 940.

Willison, H.J., Kendall, B.E., Trend, P., Thomas, P.K., Symon, L., and Thrush, D. (1990) Spinal arteriovenous malformation unmasked during intravenous urography. Journal of Neurology, Neurosurgery and Psychiatry, 53(2), pp. 175-176.

Quarles, R.H., Ilyas, A.A., and Willison, H.J. (1990) Antibodies to gangliosides and myelin proteins in Guillain-Barré syndrome. Annals of Neurology, 27(Sup. 1), S48-S52. (doi:10.1002/ana.410270713)

Willison, H.J., Trapp, B.D., Bacher, J.D., Dalakas, M.C., Griffin, J.W., and Quarles, R.H. (1988) Demyelination induced by intraneural injection of human antimyelin-associated glycoprotein antibodies. Muscle and Nerve, 11(11), pp. 1169-1176. (doi:10.1002/mus.880111111)

Ilyas, A.A., Willison, H.J., Dalakas, M.C., Whitaker, J.N., and Quarles, R.H. (1988) Identification and characterization of gangliosides reacting with IgM paraproteins in three patients with neuropathy associated with biclonal gammopathy. Journal of Neurochemistry, 51(3), pp. 851-858. (doi:10.1111/j.1471-4159.1988.tb01821.x)

Ilyas, A.A., Willison, H.J., Quarles, R.H., Jungalwala, F.B., Cornblath, D.R., Trapp, B.D., Griffin, D.E., Griffin, J.W., and McKhann, G.M. (1988) Serum antibodies to gangliosides in Guillain-Barré syndrome. Annals of Neurology, 23(5), pp. 440-447. (doi:10.1002/ana.410230503)

Willison, H.J., Trapp, B.D., Bacher, J.D., and Quarles, R.H. (1988) The expression of myelin-associated glycoprotein in regenerating cat sciatic nerve. Brain Research, 444(1), pp. 10-16. (doi:10.1016/0006-8993(88)90907-9)

Willison, H.J., Ilyas, A.I., O'Shannessy, D.J., Pulley, M., Trapp, B.D., and Quarles, R.H. (1987) Myelin-associated glycoprotein and related glycoconjugates in developing cat peripheral nerve: a correlative biochemical and morphometric study. Journal of Neurochemistry, 49(6), pp. 1853-1862. (doi:10.1111/j.1471-4159.1987.tb02447.x)

Quarles, R.H., Ilyas, A.A., and Willison, H.J. (1986) Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system. Chemistry and Physics of Lipids, 42(1-3), pp. 235-248. (doi:10.1016/0009-3084(86)90055-1)

Ilyas, A.A., Dobersen, M.J., Willison, H.J., and Quarles, R.H. (1986) Mouse monoclonal and rabbit polyclonal antibodies prepared to human myelin-associated glycoprotein also react with glycosphingolipids of peripheral nerve. Journal of Neuroimmunology, 12(2), pp. 99-106. (doi:10.1016/0165-5728(86)90023-8)

Willison, H.J., Minna, J.D., Brady, R.O., and Quarles, R.H. (1986) Glycoconjugates in nervous tissue and small cell lung cancer share immunologically cross-reactive carbohydrate determinants. Journal of Neuroimmunology, 10(4), pp. 353-365. (doi:10.1016/S0165-5728(86)90018-4)

Willison, H.J., Muller, D.P., Matthews, S., Jones, S., Kriss, A., Stead, R.J., Hodson, M.E., and Harding, A.E. (1985) A study of the relationship between neurological function and serum vitamin E concentrations in patients with cystic fibrosis. Journal of Neurology, Neurosurgery and Psychiatry, 48(11), pp. 1097-1102.

O'Shannessy, D.J., Willison, H.J., Inuzuka, T., Dobersen, M.J., and Quarles, R.H. (1985) The species distribution of nervous system antigens that react with anti-myelin-associated glycoprotein antibodies. Journal of Neuroimmunology, 9(5), pp. 255-268. (doi:10.1016/S0165-5728(85)80024-2)

Harding, A.E., Muller, D.P., Thomas, P.K., and Willison, H.J. (1982) Spinocerebellar degeneration secondary to chronic intestinal malabsorption: a vitamin E deficiency syndrome. Annals of Neurology, 12(5), pp. 419-424.

This list was generated on Sun Aug 2 23:25:21 2015 BST.